Almost two-thirds of Americans now give the pharma industry a thumbs up. It’s a stunning reversal from just one year ago when only about one-third (32%) rated the industry positively. What does this mean for drug pricing reform? JPA Health’s Public Affairs team takes on the drug pricing reform debate with a specific focus on health public affairs.

Don’t miss an episode of ELEVATE, subscribe to our podcast on Apple Podcasts, Spotify, and Google Podcasts.